medline.ch Onkologie Urologische Tumoren

	LINC00222 regulates FOXO3 to interfere with Î²-catenin signaling pathway and suppresses prostate cancer progression. Sci Rep Li H, Zhao W, Deng Y, Liu Z, Li J, Tian S. PMID: 42315881 [PubMed - as supplied by publisher]
	Lutetium-177-PSMA I&T (Lu-PSMA) with radiosensitising capecitabine in patients with metastatic castration-resistant prostate cancer (mCRPC): results of phase Ia study. Eur J Nucl Med Mol Imaging Leslie C, Al-Ogaili Z, Oh L, Slattery T, Shaji S, Marsavela G, Mills A, Stone C, Ferguson T. PMID: 42315637 [PubMed - as supplied by publisher]
	The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of hormone-sensitive prostate cancer - study protocol. BMJ Open van der Gaag S, Vis A, Bartelink I, Hendrikse H, Oprea-Lager DE. PMID: 42315278 [PubMed - indexed for MEDLINE]
	Retzius-Sparing Laparoscopic Radical Prostatectomy in A Nonrobotic Setting: A 30-Case Implementation Series With Minimum 18-Month Follow-Up. Asian J Endosc Surg Fernandez-Alberti J, Ernst G, Scolari G, Lopez AV, Panzardi N, Featherston M, Martinez PM. PMID: 42315251 [PubMed - indexed for MEDLINE]
	Elevated allostatic load, adverse body composition, and reduced overall survival in a retrospective cohort of men with newly diagnosed metastatic prostate cancer. J Acad Nutr Diet Sheean PM, O'Connor P, Bolouri M, Wozniak A, Joyce C, Vasilopoulos V, Badami A. PMID: 42314899 [PubMed - as supplied by publisher]
	Antidiabetic medications and the risk of bladder cancer in patients with diabetes mellitus: A systematic review and meta-analysis. Urol Oncol Lei D, Wu JH, Zeng XH, Xu R, Zheng SS, Zhu XJ, Yang JA. PMID: 42314323 [PubMed - as supplied by publisher]
	Mechanisms of resistance to androgen deprivation therapy in prostate cancer. Mol Aspects Med Bensalim I, Belyamani L, Boutayeb S, Bourais I. PMID: 42314224 [PubMed - as supplied by publisher]
	Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI-RADS 3 Lesions: A Two-Center Retrospective Study. Prostate Eroglu A, Gezmis CT, Arikan Y, Cilesiz NC, Koras O, Emir B, Balci MBC, Keskin MZ. PMID: 42314010 [PubMed - as supplied by publisher]
	Metabolic Reprogramming in Renal Cell Carcinoma: A Scoping Review with Quantitative Integration of Metabolomic Studies. J Proteome Res Amaro F, Carvalho M, Bastos ML, Guedes de Pinho P, Pinto J. PMID: 42313837 [PubMed - as supplied by publisher]
	Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Nonrandomized Clinical Trial. JAMA Oncol Zilli T, Franzese C, Guckenberger M, Giaj-Levra N, Mach N, Achard V, Vial N, McDonald A, Alongi F, Scorsetti M, Constantin G, Bertaut A, Miralbell R. PMID: 42313395 [PubMed - as supplied by publisher]
	Downregulation of long non-coding RNAs PCAT18, HOTAIR, and CTBP1-AS in prostate malignancies. Mol Biol Rep Pouresmaeili F, Mohammadi M, Hosseini J, Aarabi A, Fazeli Z, Tabatabaie SFS. PMID: 42313281 [PubMed - indexed for MEDLINE]
	Association between the G-protein-coupled estrogen receptor 1 and prostate cancer in the Slovak population. Mol Biol Rep Me, Kliment J, Du, Evin D, Kno, Kme, Dobrota D, Jure. PMID: 42313278 [PubMed - indexed for MEDLINE]
	Preoperative MRI Model for Predicting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma with Tumor Thrombus. Radiol Imaging Cancer Wen XW, Zhou SP, Kang HH, Zhao J, Bai X, Wang MF, Chen YB, Yi SC, Li CB, Ding XH, Huang QB, Wang HY. PMID: 42313081 [PubMed - indexed for MEDLINE]
	Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis. Radiol Imaging Cancer Ulaner GA, Parihar AS, Calais J, Sutcliffe S, Schoones JW. PMID: 42313080 [PubMed - indexed for MEDLINE]
	The evolution of kidney surgery for renal masses in Switzerland - a retrospective analysis. Swiss Med Wkly Schmid FA, Schütz L, Blum M, Wildisen L, Staehelin K, Mousavi M, Scherer TP, Strebel RT. PMID: 42312990 [PubMed - indexed for MEDLINE]
	Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Future Oncol Bryce AH, Nash P, Roessler A, Mandair D. PMID: 42312474 [PubMed - as supplied by publisher]
	Metanephric Stromal Tumor of the Kidney in 9-year-old boy: Diagnostic Dilemma and Nephron-Sparing Approach. J Indian Assoc Pediatr Surg Prajapati P, Kumar T, Kumar B, Mathew P. PMID: 42312273 [PubMed]
	1H MR-based detection of human plasma metabolic alterations in clear cell renal cell carcinoma. BJUI Compass Sharma RK, Solaiyappan M, Feinaj A, Brönimann S, Singla N, Bhujwalla ZM, Ged Y. PMID: 42311813 [PubMed]
	Gold Nanoparticle Radiosensitization for High-Dose-Rate Brachytherapy: Differential Efficacy of PEG- and RGD-Functionalized Gold Nanoparticles Across 2-Dimensional, 3-Dimensional, and in vivo Prostate Cancer Models. Int J Nanomedicine Cecchi D, Jackson N, Karaman D, Beckham W, Johnstone CD, Lloyd SAM, Chithrani D. PMID: 42311423 [PubMed - indexed for MEDLINE]
	Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance. Front Oncol Yu D, Tang J, Zhang Y, Hu K, Qing J, Zhang J. PMID: 42311269 [PubMed]

Artikel 1 - 20 / 179100

Seite 1 von 8955

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung